Browse > Article

Early-stage Diagnosis of Bladder Carcinoma by a Clinical Pharmacist's Effective Anti-coagulation Service in a Patient with Anticoagulation Therapy: a Clinical Case Report  

An, Sung-Shim (Department of Pharmacy, Seoul St. Mary's Hospital, The Catholic University of Korea)
Bang, Joon-Seok (Department of Pharmacy, Seoul St. Mary's Hospital, The Catholic University of Korea)
La, Hyen-Oh (Department of Pharmacology, College of Medicine, The Catholic University of Korea)
Publication Information
Korean Journal of Clinical Pharmacy / v.20, no.1, 2010 , pp. 85-87 More about this Journal
Abstract
Recently, the prevalence of bladder cancer is increasing in the Korean society. As the risk factors of bladder carcinoma are variable, the early-stage diagnosis is regarded the best preventive practice. Hematuria is a specific sign of the malignancy as well as a kind of various medication-related adverse reactions. Some anti-coagulation therapy can cause bleedings including hematuria to the patients with cardiovascular diseases such as paroxysmal atrial fibrillation (PAF). Therefore, to the clinical pharmacists working in the anti-coagulation services (ACS), a closer monitoring of patients can give an opportunity to find certain ailments unexpectedly. In this case, a patient with PAF had episodes of sporadic hematuria in the course of warfarin therapy even though with its low levels of INR. An ACS pharmacist found a discrepancy between the bleeding symptoms and INR values, and recommended properly the patient to refer urologist. Fortunately, an early-stage of bladder carcinoma was found then followed by an excision performed to the lesion. Therefore, alert-minded and precise monitoring done by ACS pharmacist could optimize the therapeutic outcomes as well as increase the quality of life of the patient.
Keywords
bladder carcinoma; hematuria; anticoagulation; warfarin; INR; ACS;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lesho EP, Saullo L, Udvari-Nagi S. A 76-year-old woman with erratic anticoagulation. Cleve Clin J Med 2004; 71(8): 651-6.   DOI   ScienceOn
2 Cuttino JT, Clark RL, Feaster SH, et al., The Evaluation of Gross Hematuria in Anticoagulated Patients: Efficacy of IV Urography and Cystoscopy. AJR 1987; 149: 527-8.   DOI   ScienceOn
3 Grossman HB, Messing E, Soloway M, et al., Detection of Bladder Cancer Using a Point-of-Care Proteomic Assay. JAMA 2005; 293(7): 810-6.   DOI   ScienceOn
4 Schattner A. Detecting bladder cancer. BMJ 1990; 301: 1278-9.
5 Froom P, Ribak J, Benbassat J. Significance of microhaematuria in young adults. BMJ 1984; 288: 20-22.   DOI
6 Friedman GD, Carroll PR, Cattolica EV, et al., Can Hematuria Be a Predictor as well as a Symptom or Sign of Bladder Cancer? Cancer Epidemiol Biomarkers Prev 1996; 5: 993-6.
7 Rodgers M, Nixon J, Hempel S, et al., Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation. Health Technology Assessment 2006; 10(18): 1-282.
8 Pashos CL, Botteman MF, Laskin BL, et al., Bladder Cancer Epidemiology, Diagnosis, and Management. Cancer Practice 2002; 10(6): 311-322.   DOI   ScienceOn
9 국가암등록사업 연례 보고서. 보건복지가족부 중앙암등록본부 2009.12
10 국민건강영양조사 제4기 2차년도(2008) 결과 발표회 자료집(acquired from website on December 28, 2009. http:// knhanes.cdc.go.kr/data/data05.jsp)